{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T19:05:13Z","timestamp":1775243113969,"version":"3.50.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Inform Decis Mak"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12911-015-0225-8","type":"journal-article","created":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:18:53Z","timestamp":1449015533000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Estimating the value of medical treatments to patients using probabilistic multi criteria decision analysis"],"prefix":"10.1186","volume":"15","author":[{"given":"Henk","family":"Broekhuizen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catharina G. M.","family":"Groothuis-Oudshoorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. Brett","family":"Hauber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeroen P.","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maarten J.","family":"IJzerman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,12,2]]},"reference":[{"key":"225_CR1","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.orhc.2013.03.001","volume":"2","author":"V Diaby","year":"2013","unstructured":"Diaby V, Campbell K, Goeree R. Multi-criteria decision analysis (MCDA) in health care: a bibliometric analysis. Oper Res Heal Care. 2013;2:20\u20134. doi: 10.1016\/j.orhc.2013.03.001 .","journal-title":"Oper Res Heal Care"},{"key":"225_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40273-013-0118-6","volume":"32","author":"K Marsh","year":"2014","unstructured":"Marsh K, Lanitis T, Neasham D, Orfanos P, Caro J. Assessing the value of healthcare interventions using multi-criteria decision analysis: a review of the literature. Pharmacoeconomics. 2014;32:1\u201321.","journal-title":"Pharmacoeconomics"},{"key":"225_CR3","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4615-1495-4","volume-title":"Multiple criteria decision analysis: an integrated approach","author":"V Belton","year":"2002","unstructured":"Belton V, Stewart TJ. Multiple criteria decision analysis: an integrated approach. 2nd ed. Dordrecht: Kluwer Academic Publishers; 2002.","edition":"2"},{"key":"225_CR4","unstructured":"Dodgson JS, Spackman M, Pearman A, Phillips L. Multi-criteria analysis: a manual. Department for Communities and Local Government; 2009. http:\/\/eprints.lse.ac.uk\/12761\/ . Accessed 30 Nov 2015."},{"key":"225_CR5","unstructured":"Hughes D, Waddingham E, Mt-isa S, Goginsky A, Chan E, Downey G, et al. Recommendations for the methodology and visualisation techniques to be used in the assessment of benefit and risk of medicines. IMI-PROTECT. http:\/\/www.imi-protect.eu\/benefitsRep.shtml . Accessed 30 Nov 2015."},{"key":"225_CR6","doi-asserted-by":"crossref","unstructured":"Ishizaka A, Nemery P. Multi-criteria decision analysis: methods and software. 1st ed. John Wiley & Sons Ltd; 2013. doi: 10.1002\/9781118644898 .","DOI":"10.1002\/9781118644898"},{"key":"225_CR7","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1002\/pds.1435","volume":"16","author":"F Mussen","year":"2007","unstructured":"Mussen F, Salek S, Walker S. A quantitative approach to benefit-risk assessment of medicines \u2014 part 1: the development of a new model using multi-criteria decision analysis. Pharmacoepidemiol Drug Saf. 2007;16:S2\u2013S15. doi: 10.1002\/pds .","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"225_CR8","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1177\/0272989X08323299","volume":"29","author":"JC Felli","year":"2009","unstructured":"Felli JC, Noel RA, Cavazzoni PA. A multiattribute model for evaluating the benefit-risk profiles of treatment alternatives. Med Decis Mak. 2009;29:104\u201315. doi: 10.1177\/0272989X08323299 .","journal-title":"Med Decis Mak"},{"key":"225_CR9","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s40271-014-0050-7","volume":"7","author":"JM Hummel","year":"2014","unstructured":"Hummel JM, Bridges JFP, IJzerman MJ. Group decision making with the analytic hierarchy process in benefit-risk assessment: a tutorial. Patient. 2014;7:129\u201340. doi: 10.1007\/s40271-014-0050-7 .","journal-title":"Patient"},{"key":"225_CR10","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1586\/14737167.2014.859525","volume":"14","author":"V Diaby","year":"2014","unstructured":"Diaby V, Goeree R. How to use multi-criteria decision analysis methods for reimbursement decision-making in healthcare: a step-by-step guide. Expert Rev Pharmacoecon Outcomes Res. 2014;14:81\u201399. doi: 10.1586\/14737167.2014.859525 .","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"225_CR11","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1177\/0272989X11416870","volume":"32","author":"MM Goetghebeur","year":"2012","unstructured":"Goetghebeur MM, Wagner M, Khoury H, Levitt RJ, Erickson LJ, Rindress D. Bridging health technology assessment (HTA) and efficient health care decision making with multicriteria decision analysis (MCDA): applying the EVIDEM framework to medicines appraisal. Med Decis Mak. 2012;32:376\u201388. doi: 10.1177\/0272989X11416870 .","journal-title":"Med Decis Mak"},{"key":"225_CR12","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1186\/1472-6963-11-329","volume":"11","author":"M Tony","year":"2011","unstructured":"Tony M, Wagner M, Khoury H, Rindress D, Papastavros T, Oh P, et al. Bridging health technology assessment (HTA) with multicriteria decision analyses (MCDA): field testing of the EVIDEM framework for coverage decisions by a public payer in Canada. BMC Health Serv Res. 2011;11:329. doi: 10.1186\/1472-6963-11-329 .","journal-title":"BMC Health Serv Res"},{"key":"225_CR13","doi-asserted-by":"crossref","unstructured":"van Til JA, IJzerman MJ. Why Should Regulators Consider Using Patient Preferences in Benefit-risk Assessment? Pharmacoeconomics 2013;10\u20133. doi: 10.1007\/s40273-013-0118-6 .","DOI":"10.1007\/s40273-013-0118-6"},{"key":"225_CR14","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1017\/S0266462310000395","volume":"26","author":"K Facey","year":"2010","unstructured":"Facey K, Boivin A, Gracia J, Hansen HP, Lo Scalzo A, Mossman J, et al. Patients\u2019 perspectives in health technology assessment: a route to robust evidence and fair deliberation. Int J Technol Assess Health Care. 2010;26:334\u201340. doi: 10.1017\/S0266462310000395 .","journal-title":"Int J Technol Assess Health Care"},{"key":"225_CR15","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1017\/S0266462307051549","volume":"23","author":"JFP Bridges","year":"2007","unstructured":"Bridges JFP, Jones C. Patient-based health technology assessment: a vision of the future. Int J Technol Assess Health Care. 2007;23:30\u20135. doi: 10.1017\/S0266462307051549 .","journal-title":"Int J Technol Assess Health Care"},{"key":"225_CR16","unstructured":"MDIC PCBR project group members. A framework for incorporating information of patient preferences regarding benefit and risk into regulatory assessments of new medical technology. Medical Device Innovation Consortium; 2015. http:\/\/mdic.org\/PCBR\/ . Accessed 30 Nov 2015."},{"key":"225_CR17","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s40258-013-0028-y","volume":"11","author":"A Brett Hauber","year":"2013","unstructured":"Brett Hauber A, Fairchild AO, Reed JF. Quantifying benefit-risk preferences for medical interventions: an overview of a growing empirical literature. Appl Health Econ Health Policy. 2013;11:319\u201329. doi: 10.1007\/s40258-013-0028-y .","journal-title":"Appl Health Econ Health Policy"},{"key":"225_CR18","doi-asserted-by":"crossref","unstructured":"Weernink MGM, Janus SIM, van Til J a, Raisch DW, van Manen JG, IJzerman MJ. A Systematic Review to Identify the Use of Preference Elicitation Methods in Healthcare Decision Making. Pharmaceut Med 2014. doi: 10.1007\/s40290-014-0059-1 .","DOI":"10.1007\/s40290-014-0059-1"},{"key":"225_CR19","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.jclinepi.2011.09.005","volume":"65","author":"G Valkenhoef van","year":"2012","unstructured":"van Valkenhoef G, Tervonen T, Zhao J, de Brock B, Hillege HL, Postmus D. Multicriteria benefit-risk assessment using network meta-analysis. J Clin Epidemiol. 2012;65:394\u2013403. doi: 10.1016\/j.jclinepi.2011.09.005 .","journal-title":"J Clin Epidemiol"},{"issue":"5","key":"225_CR20","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1177\/0272989X12458348","volume":"32","author":"AH Briggs","year":"2012","unstructured":"Briggs AH, Weinstein MC, Fenwick EAL, Karnon J, Sculpher MJ, Paltiel AD. Model parameter estimation and uncertainty: a report of the ISPOR-SMDM modeling good research practices task force-6. Med Decis Making. 2012;32(5);722-33. doi: 10.1177\/0272989X12458348 .","journal-title":"Med Decis Making"},{"issue":"9","key":"225_CR21","doi-asserted-by":"crossref","first-page":"781","DOI":"10.2165\/00019053-200826090-00008","volume":"26","author":"K Claxton","year":"2008","unstructured":"Claxton K. Exploring Uncertainty in Cost-Effectiveness Analysis. Pharmacoeconomics. 2008;26(9):781\u201398.","journal-title":"Pharmacoeconomics"},{"key":"225_CR22","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s40273-014-0251-x","volume":"33","author":"H Broekhuizen","year":"2015","unstructured":"Broekhuizen H, Groothuis-Oudshoorn C, van Til J, Hummel M, IJzerman M. A review and classification of approaches for dealing with uncertainty in multi-criteria decision analysis for healthcare decisions. Pharmacoeconomics. 2015;33:445\u201355.","journal-title":"Pharmacoeconomics"},{"key":"225_CR23","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","volume":"23","author":"M Hamilton","year":"1960","unstructured":"Hamilton M. A rating scale for depression. Neurol Neurosurg Psychiatry. 1960;23:56\u201362.","journal-title":"Neurol Neurosurg Psychiatry"},{"key":"225_CR24","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","volume":"134","author":"S Montgomery","year":"1979","unstructured":"Montgomery S, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134:382\u20139.","journal-title":"Br J Psychiatry"},{"key":"225_CR25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF03262495","volume":"5","author":"JM Hummel","year":"2012","unstructured":"Hummel JM, Volz F, van Manen JG, Danner M, Dintsios CM, IJzerman MJ, et al. Using the analytic hierarchy process to elicit patient preferences. Patient. 2012;5:1\u201313.","journal-title":"Patient"},{"key":"225_CR26","unstructured":"R Development Core Team. R: A Language and Environment for Statistical Computing 2012. http:\/\/www.rproject.org . Accessed 30 Nov 2015."},{"key":"225_CR27","volume-title":"Decisions with multiple objectives","author":"R Keeney","year":"1976","unstructured":"Keeney R, Raiffa H. Decisions with multiple objectives. Cambridge: Cambridge University Press; 1976."},{"key":"225_CR28","doi-asserted-by":"crossref","first-page":"853","DOI":"10.2165\/00002018-200326120-00002","volume":"26","author":"W Holden","year":"2003","unstructured":"Holden W. Benefit-risk analysis: A brief review and proposed quantitative approaches. Drug Saf. 2003;26:853\u201362.","journal-title":"Drug Saf"},{"key":"225_CR29","doi-asserted-by":"crossref","unstructured":"Shaffer ML, Watterberg KL. Joint distribution approaches to simultaneously quantifying benefit and risk. BMC Med Res Methodol 2006;6. doi: 10.1186\/1471-2288-6-48 .","DOI":"10.1186\/1471-2288-6-48"},{"key":"225_CR30","first-page":"1","volume":"13","author":"LD Lynd","year":"2009","unstructured":"Lynd LD, Najafzadeh M, Colley L, Byrne MF, Willan AR, Sculpher MJ, et al. Using the incremental net benefit framework for quantitative benefit-risk analysis in regulatory decision-making - a case study of alosetron in irritable bowel syndrome. Value Heal. 2009;13:1\u20137. doi: 10.1111\/j.1524-4733.2009.00595.x .","journal-title":"Value Heal"},{"key":"225_CR31","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1002\/pds.1994","volume":"19","author":"LD Lynd","year":"2010","unstructured":"Lynd LD, Marra CA, Najafzadeh M, Sadatsafavi M. A quantitative evaluation of the regulatory assessment of the benefits and risks of rofecoxib relative to naproxen: an application of the incremental net-benefit framework. Pharmacoepidemiol Drug Saf. 2010;19:1172\u201380. doi: 10.1002\/pds .","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"225_CR32","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.jval.2014.04.008","volume":"17","author":"S Wen","year":"2014","unstructured":"Wen S, Zhang L, Yang B. Two approaches to incorporate clinical data uncertainty into multiple criteria decision analysis for benefit-risk assessment of medicinal products. Value Heal. 2014;17:619\u201328. doi: 10.1016\/j.jval.2014.04.008 .","journal-title":"Value Heal"},{"key":"225_CR33","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1002\/sim.4194","volume":"30","author":"T Tervonen","year":"2011","unstructured":"Tervonen T, van Valkenhoef G, Buskens E, Hillege HL, Postmus D. A stochastic multicriteria model for evidence-based decision making in drug benefit-risk analysis. Stat Med. 2011;30:1419\u201328. doi: 10.1002\/sim.4194 .","journal-title":"Stat Med"},{"key":"225_CR34","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1177\/0272989X12451338","volume":"32","author":"O Caster","year":"2012","unstructured":"Caster O, Nor\u00e9n GN, Ekenberg L, Edwards IR. Quantitative benefit-risk assessment using only qualitative information on utilities. Med Decis Mak. 2012;32:E1\u2013E15. doi: 10.1177\/0272989X12451338 .","journal-title":"Med Decis Mak"},{"key":"225_CR35","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jval.2014.12.001","volume":"18","author":"DA Marshall","year":"2015","unstructured":"Marshall DA, Burgos Liz L, Eng II, Ijzerman MJ, Osgood ND, Padula WV, et al. Applying dynamic simulation modeling methods in health care delivery research \u2014 the simulate checklist\u202f: report of the ispor simulation modeling emerging good practices task force. Value Heal. 2015;18:5\u201316. doi: 10.1016\/j.jval.2014.12.001 .","journal-title":"Value Heal"},{"key":"225_CR36","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/1471-2288-14-130","volume":"14","author":"PJ Giabbanelli","year":"2014","unstructured":"Giabbanelli PJ, Crutzen R. Creating groups with similar expected behavioural response in Randomized Controlled Trials: a fuzzy cognitive map approach. BMC Med Res Methodol. 2014;14:130.","journal-title":"BMC Med Res Methodol"},{"key":"225_CR37","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.pec.2008.07.032","volume":"73","author":"JG Dolan","year":"2008","unstructured":"Dolan JG. Shared decision-making--transferring research into practice: the Analytic Hierarchy Process (AHP). Patient Educ Couns. 2008;73:418\u201325. doi: 10.1016\/j.pec.2008.07.032 .","journal-title":"Patient Educ Couns"},{"key":"225_CR38","first-page":"5","volume":"9","author":"N Zafiropoulos","year":"2012","unstructured":"Zafiropoulos N, Phillips L, Pignatti F, Luria X. Evaluating benefit-risk: An agency perspective. Regul Rapp. 2012;9:5\u20138.","journal-title":"Regul Rapp"},{"key":"225_CR39","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1472-6947-14-18","volume":"14","author":"CG Groothuis Oudshoorn","year":"2014","unstructured":"Groothuis Oudshoorn CG, Fermont JM, Van Til JA, Ijzerman MJ. Public stated preferences and predicted uptake for genome-based colorectal cancer screening. BMC Med Inform Decis Mak. 2014;14:18. doi: 10.1186\/1472-6947-14-18 .","journal-title":"BMC Med Inform Decis Mak"},{"key":"225_CR40","unstructured":"EMA. Work package 2 report: Applicability of current tools and processes for regulatory benefit-risk 2011;44:1\u201333. http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Report\/2010\/10\/WC500097750.pdf . Accessed 30 Nov 2015."},{"key":"225_CR41","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s40273-014-0211-5","volume":"33","author":"W Rogowski","year":"2015","unstructured":"Rogowski W, Payne K, Schnell-Inderst P, Manca A, Rochau U, Jahn B, et al. Concepts of \u201cpersonalization\u201d in personalized medicine: implications for economic evaluation. Pharmacoeconomics. 2015;33:49\u201359. doi: 10.1007\/s40273-014-0211-5 .","journal-title":"Pharmacoeconomics"},{"key":"225_CR42","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0360-8352(00)00019-X","volume":"37","author":"EU Choo","year":"1999","unstructured":"Choo EU, Schoner B, Wedley WC. Interpretation of criteria weights in multicriteria decision making. Comput Ind Eng. 1999;37:527\u201341. doi: 10.1016\/S0360-8352(00)00019-X .","journal-title":"Comput Ind Eng"},{"key":"225_CR43","doi-asserted-by":"crossref","first-page":"3578","DOI":"10.1016\/j.scitotenv.2011.06.022","volume":"409","author":"IB Huang","year":"2011","unstructured":"Huang IB, Keisler J, Linkov I. Multi-criteria decision analysis in environmental sciences: Ten years of applications and trends. Sci Total Environ. 2011;409:3578\u201394. doi: 10.1016\/j.scitotenv.2011.06.022 .","journal-title":"Sci Total Environ"},{"key":"225_CR44","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1016\/j.rser.2009.06.021","volume":"13","author":"J-J Wang","year":"2009","unstructured":"Wang J-J, Jing Y-Y, Zhang C-F, Zhao J-H. Review on multi-criteria decision analysis aid in sustainable energy decision-making. Renew Sustain Energy Rev. 2009;13:2263\u201378. doi: 10.1016\/j.rser.2009.06.021 .","journal-title":"Renew Sustain Energy Rev"},{"key":"225_CR45","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/S0377-2217(02)00774-9","volume":"150","author":"RE Steuer","year":"2003","unstructured":"Steuer RE, Na P. Multiple criteria decision making combined with finance: A categorized bibliographic study. Eur J Oper Res. 2003;150:496\u2013515. doi: 10.1016\/S0377-2217(02)00774-9 .","journal-title":"Eur J Oper Res"},{"key":"225_CR46","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ejor.2009.05.009","volume":"202","author":"W Ho","year":"2010","unstructured":"Ho W, Xu X, Dey PK. Multi-criteria decision making approaches for supplier evaluation and selection: A literature review. Eur J Oper Res. 2010;202:16\u201324. doi: 10.1016\/j.ejor.2009.05.009 .","journal-title":"Eur J Oper Res"}],"container-title":["BMC Medical Informatics and Decision Making"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-015-0225-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,2]],"date-time":"2019-09-02T03:58:44Z","timestamp":1567396724000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.biomedcentral.com\/1472-6947\/15\/102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["225"],"URL":"https:\/\/doi.org\/10.1186\/s12911-015-0225-8","relation":{},"ISSN":["1472-6947"],"issn-type":[{"value":"1472-6947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12]]},"article-number":"102"}}